
Orforglipron 6 mg
Orforglipron
Orforglipron (sold under the brand name Foundayo) is a once-daily oral non-peptide GLP-1 receptor agonist.
- Dosage Form
- Tablet
- Strength
- 6mg
- Pack Size
- 90 counts / vial
- Manufacturer
- Pharmos Research
Description
Orforglipron mimics the natural GLP-1 hormone to suppress appetite, slow digestion, and reduce calorie intake. Because it is a small-molecule pill, it can be taken at any time of day, with or without food or water restrictions.What the 6 mg Dose MeansDosing Schedule: Orforglipron is typically started at lower doses (such as 3 mg or 6 mg) to help the body adjust and minimize initial side effects. It is later escalated to maintenance doses ranging between 12 mg and 45 mg.Effectiveness: In clinical trials, the 6 mg dosage is associated with an average body weight reduction of roughly 5.5% to 7.5% over the course of the treatment.Packaging: A bottle of 90 capsules represents a 3-month supply (assuming the standard once-daily regimen).Key CharacteristicsMechanism: Stimulates insulin release, reduces glucagon secretion, and curbs appetite.Convenience: Unlike other oral GLP-1s, it has no strict meal-timing rules or required fasting windows prior to administration.Common Side Effects: As with other GLP-1 medications, the most frequent side effects are gastrointestinal (e.g., nausea, diarrhea, vomiting, and constipation), which are most noticeable when dosages are increased.
